General Practitioners and Participation Rate in ColoRectal Cancer Screening
NCT ID: NCT04492215
Last Updated: 2023-04-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
902 participants
INTERVENTIONAL
2021-05-31
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In France, there is organized colorectal cancer screening, which relies on general practitioners (GPs). Tests delivered by GPs are performed in 89% of cases. However, GPs do not systematically offer the test, for time management and communication reasons. Patients expect their GPs to offer the test and to focus on their expectations. A previous study conducted on GPs showed that training in communication and motivational interviewing increases the number of tests performed by 12.2%.
In order to facilitate the promotion of screening, the investigators would like to develop a training programme for GPs focusing on the application of Motivational Interviewing (MI) techniques to the promotion of colorectal cancer screening.
Motivational Interviewing is a directive, client-centered counseling style for eliciting behavior change by helping clients to explore and resolve ambivalence.
This study is a multicenter trial in general medicine. In this randomized trial the 902 subjects will be included prospectively by the general practitioners (GP) participating in the study.
As a first step, general practitioners who have never participated in Motivational Interviewing training will be recruited and split into 2 groups by randomization, an intervention group and a control group. The interventional group will then undergo a 3 times 2-day training in Motivational Interviewing.
In a second step, the patients will be included by those GP and a self-questionnaire will be send at the inclusion and after 6, 12 and 24 months. The evaluation of the number of tests performed and the analyse of the Health Belief Model (HBM) self-questionnaire will be carried out.
At 24 months, there will be an evaluation of the denial motivation questionnaire for patients who have not participated in organized colorectal cancer screening.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Teaching General Practitioners to Use the Patient-centered Approach When Suggesting Colorectal Cancer Screening
NCT03938623
Does the Recall by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?
NCT01279330
Influence of a Brief Intervention on CRC Screening
NCT02012829
A Program for Improved Family Screening for Colorectal Cancer
NCT03620877
Impact of the Distribution to Attending Physicians of a Nominative List of Their Patients Not Participating in the Organised Screening of Colorectal Cancer
NCT02515344
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Physicians trained in motivational interviewing
Patients followed by general practitioners trained in motivational interviewing
Interaction between patient and trained general practitioners in motivational interviewing
Impact of the medical interview on the patient
Physicians did not trainned in motivational interviewing
Patients followed by general practitioners who did not receive motivational interviewing.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interaction between patient and trained general practitioners in motivational interviewing
Impact of the medical interview on the patient
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* People living in Finistère.
* People aged 50 to 74 who have never participated in organized screening for colorectal cancer.
Exclusion Criteria
* People who do not fit the organized screening criteria
* Persons unable to give consent (patients under guardianship, curatorship, non-French speaking, illiterate)
50 Years
74 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr ABALAIN
Brest, , France
Dr HENRY
Brest, , France
Dr PETTON-HILI
Brest, , France
Dr DENIEL
Châteauneuf-du-Faou, , France
Dr LE BOURHIS
Châteauneuf-du-Faou, , France
Dr PERRIER
Clohars-Carnoët, , France
Dr CHAPOIX
Crozon, , France
Dr OLIVIER
Daoulas, , France
Dr ATTENCOURT
Douarnenez, , France
Dr KERVELLA
Douarnenez, , France
Dr VELLY
Ergué-Gabéric, , France
Dr BLANCHARD
Esquibien, , France
Dr DESNOT
Esquibien, , France
Dr VIALA
Esquibien, , France
Dr DAOUDAL
Fouesnant, , France
Dr LEFEVRE
Fouesnant, , France
Dr MAGADUR
Fouesnant, , France
Dr MUNCK
Guerlesquin, , France
Dr POINOT
Guerlesquin, , France
Dr LE FLOCH
Guilvinec, , France
Dr LE GRIGNOU
Guissény, , France
Dr PITMAN
Landivisiau, , France
Dr COLLETER
Lanmeur, , France
Dr CRENN-CORVEZ
Lanmeur, , France
Dr BECK-ROBERT
Lanmeur, , France
Dr BARAIS
Lannilis, , France
Dr VERBEQUE MORVAN
Le Conquet, , France
Dr TREBAOL
Le Faou, , France
Dr GRALL
Le Relecq-Kerhuon, , France
Dr BOUTERAON
Loperhet, , France
Dr PIPET-PENIN
Moëlan-sur-Mer, , France
Dr BEURTON-COURAUD
Pleyben, , France
Dr LUCAS
Pleyben, , France
Dr KERFRIDEN KERHOAS
Pleyber-Christ, , France
Dr BAUTA
Plonévez-Porzay, , France
Dr COGNEAU
Plonévez-Porzay, , France
Dr GASNIER
Ploudalmézeau, , France
Dr AOUDIA
Plouezoc'h, , France
Dr LOPIN
Plougonven, , France
Dr DROGOU
Plouhinec, , France
Dr BODIN
Plounéour-Trez, , France
Dr DE LA SOUDIERE
Plouzané, , France
Dr PETIT
Pont-l'Abbé, , France
Dr PREVOT
Pouldreuzic, , France
Dr AUTRET
Quimper, , France
Dr COROLLER
Quimper, , France
Dr COUTURIER
Quimper, , France
Dr JOLIVET COUTURE
Quimper, , France
Dr KERGASTEL
Quimper, , France
Dr BARCELO
Saint-Martin-des-Champs, , France
Dr MONFORT
Saint-Yvi, , France
Dr MAILLEUCHET
Spézet, , France
Dr NICOLAS
Trégunc, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Aurélie ABALAIN, Dr
Role: primary
Pierre HENRY, Dr
Role: primary
Anne-Laure PETTON-HILI, Dr
Role: primary
Magalie DENIEL, Dr
Role: primary
Erwan LE BOURHIS, Dr
Role: primary
Isabelle Clohars-Carnoët, Dr
Role: primary
Nicolas CHAPOIX, Dr
Role: primary
Eric OLIVIER, Dr
Role: primary
Christophe ATTENCOURT, Dr
Role: primary
Sylvie KERVELLA, Dr
Role: primary
Jean-François VELLY, Dr
Role: primary
Julie BLANCHARD, Dr
Role: primary
Richard DESNOT, Dr
Role: primary
Jeanlin VIALA, Dr
Role: primary
Aurore DAOUDAL, Dr
Role: primary
Maxime LEFEVRE, Dr
Role: primary
Véronique MAGADUR, Dr
Role: primary
Pauline MUNCK, Dr
Role: primary
Anne POINOT, Dr
Role: primary
Bernard LE FLOCH, Dr
Role: primary
Caroline LE GRIGNOU, Dr
Role: primary
Roberto PITMAN, Dr
Role: primary
Manuel COLLETER, Dr
Role: primary
Hélène CRENN-CORVEZ, Dr
Role: primary
Emilie BECK-ROBERT, Dr
Role: primary
Marie BARAIS, Dr
Role: primary
Manon VERBEQUE MORVAN, Dr
Role: primary
Emmanuelle TREBAOL, Dr
Role: primary
Olivier GRALL, Dr
Role: primary
Sylvie BOUTERAON, Dr
Role: primary
Gaëlle PIPET-PENIN, Dr
Role: primary
Lucas BEURTON-COURAUD, Dr
Role: primary
Aldric LUCAS, Dr
Role: primary
Morgane KERFRIDEN KERHOAS, Dr
Role: primary
Vincent BAUTA, Dr
Role: primary
Clément COGNEAU, Dr
Role: primary
Anne-Laure GASNIER, Dr
Role: primary
Seddik AOUDIA, Dr
Role: primary
Céline LOPIN, Dr
Role: primary
Marine DROGOU, Dr
Role: primary
Bénédicte BODIN, Dr
Role: primary
Ségolène DE LA SOUDIERE, Dr
Role: primary
Elisabeth PETIT, Dr
Role: primary
Jeanne PREVOT, Dr
Role: primary
Hervé AUTRET, Dr
Role: primary
Philippe COROLLER, Dr
Role: primary
Thomas COUTURIER, Dr
Role: primary
Anne JOLIVET COUTURE, Dr
Role: primary
Hélène KERGASTEL, Dr
Role: primary
Luc BARCELO, Dr
Role: primary
Xavier MONFORT, Dr
Role: primary
Jean-François MAILLEUCHET, Dr
Role: primary
Anne-Catherine NICOLAS, Dr
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Aujoulat P, Le Goff D, Dany A, Robaskiewick M, Nousbaum JB, Derrienic J, Cariou M, Guillou M, Le Reste JY. Improvement of participation rate in colorectal cancer (CRC) screening by training general practitioners in motivational interviewing (AmDepCCR). Trials. 2022 Feb 14;23(1):144. doi: 10.1186/s13063-022-06056-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A01776-51
Identifier Type: OTHER
Identifier Source: secondary_id
29BRC19.0115 (AMDepCCR)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.